Biochemistry Analyzers Market Upcoming Trends, Demand and Analysis Till 2026

Instruments such as analyzers that are used in biochemistry are becoming technologically advanced in terms of precision and speed. The accuracy of biochemistry analyzers in analyzing urine and blood samples have benefited diagnostic centers and pathology labs in recent years. Moreover, modular design of these products are gaining significant attention. The varied demand of clinical laboratory business have generated the need for designing analyzers with wide range of capabilities and features. Fully automatic biochemistry analyzer analyzes many biochemical parameters of a blood sample such as protein, urea, and blood glucose, to detect various diseases associated with liver, kidney, and other metabolic disorders. Semi-automatic biochemistry analyzer is designed to measure various chemicals and other characteristics in a number of biological samples quickly. It measures the biochemical indexes of the sample and then, combines with other clinical information to help in identifying the disease and disease gene, evaluate organ functions, and determine the method of future therapy.

Download PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1873

Market Dynamics

The major factors driving biochemistry analyzers market growth include rapid growth in diagnostics market due to increasing number of diseases and rising healthcare spending. With rising number of point-of-care testing (POCT) and advancement in technologies, demand for laboratory medicine, and the need for routine biochemical analysis are changing. Furthermore, with the developments in laboratory medicine, testing equipment are updated constantly and the requirements for medical standards have gradually increased, which further boosts growth of the biochemistry analyzers market. However, high cost of tests and shortage of highly qualified and trained personnel are some of the factors restraining growth of the market. Also, due to difference in instrument reagents, test procedures, test standards, and maintenance programs, different instruments show different results for the same test parameters in different biochemical detection systems, which leads to incomparability of the test results between different instruments.

Development of technologically advanced analyzers is expected to boost market revenue

Conventional biochemistry analyzers that are used for repetitive analysis require large amount of reagents and time. However, the technologically advanced analyzers are capable of automating the process of repetitive sample analysis that were earlier done by lab technicians. Industry players are developing biochemistry analyzers with feature of positive identification that decreases the process of repeated pathogen testing. This feature is important for samples with low volume such as neonatal units. Fully automated biochemistry analyzers can perform functions such as recognition of sample and reagent bottles, cap piercing, tube sampling, dilution, and automatic re-run, which reduces human effort and time, and require lesser volumes of reagent and sample. These analyzers aid scientists in measuring the concentration of any substance in a reaction mixture. Therefore, the implementation of IT and automation in these analyzers is expected to drive the global biochemistry analyzers market growth. Furthermore, integrated systems that combine immunochemistry and biochemistry tests are gaining huge attention. It increases the workflow efficiency and deliver fast turnaround and high throughput. It also helps in achieving increased instrument capacity by connecting different analyzer units with a single sample presentation mechanism. These systems are offered by manufacturers such as Roche, Siemens, Abbott, and Beckman Coulter.

Increasing R&D for low cost analyzers is expected to drive market growth

Increasing number of samples to be analyzed is increasing the demand for faster analytical methods that are capable of providing better information for decision making. The need for automated analyzers for environmental and industrial samples has increased the research for new and cost-effective strategies of automation and control of analytical systems. The widespread availability of open-source hardware along with novel analytical methods have opened the possibility of implementing standalone automated analytical systems at low cost. For instance, in 2011, Horiba Medical Ltd, Japan, received the Food and Drug Administration approval for Pentra C200, a fully automated bench-top analyzer that was designed as an economical option for smaller laboratories. However, new regulatory requirements such as RoHS have added complexity to instrument designing. High cost of tests and shortage of highly qualified and trained personnel are other factors restraining growth of the biochemistry analyzers market.

Global Key Players:
Some of the major players operating in the global biochemistry analyzers market are Abbott, Danaher Corporation, F.Hoffman-La Roche Ltd., Siemens AG, Thermo Fisher Scientific, Inc., Randox Laboratories Ltd., Meril, Hologic Inc., Beckman Coulter Inc., and Horiba Medical.

Detailed Segmentation:

Global Biochemistry Analyzers Market, By Product Type:
Semi-Automatic, Fully Automatic

Global Biochemistry Analyzers Market, By Modality:
Bench Top, Floor Standing

Global Biochemistry Analyzers Market, By End User:
Hospitals, Diagnostics Centers, Pharmaceutical and Biotechnology Companies, Academic Research Institutes, Contract Research Organizations

Request For Customization @ https://www.coherentmarketinsights.com/insight/request-customization/1873

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.